|
Volumn 146, Issue 21, 2004, Pages 47-50
|
New options in the treatment of various forms of diabetic neuropathy;Neue therapieoptionen bei verschiedenen formen der diabetischen neuropathie
|
Author keywords
Care pathway; Diabetic neuropathy; Duloxetine; Gabapentin; Guidelines; Neuropathic pain; PDE5 Inhibitors; Pregabalin; Ruboxistaurin
|
Indexed keywords
CARBAMAZEPINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DULOXETINE;
GABAPENTIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PHOSPHODIESTERASE V INHIBITOR;
PREGABALIN;
PROTEIN KINASE C INHIBITOR;
RUBOXISTAURIN;
SILDENAFIL;
TADALAFIL;
TRICYCLIC ANTIDEPRESSANT AGENT;
VARDENAFIL;
ANALGESIC AGENT;
ANTIDIABETIC AGENT;
INSULIN;
AUTONOMIC NEUROPATHY;
DIABETIC FOOT;
DIABETIC NEUROPATHY;
EVIDENCE BASED MEDICINE;
GERMANY;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
MEDICAL SOCIETY;
NEUROPATHIC PAIN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
SHORT SURVEY;
VISUAL ANALOG SCALE;
WORLD HEALTH ORGANIZATION;
ARTICLE;
MULTIMODALITY CANCER THERAPY;
PAIN ASSESSMENT;
PRACTICE GUIDELINE;
SOMATOSENSORY DISORDER;
ANALGESICS;
AUTONOMIC NERVOUS SYSTEM DISEASES;
COMBINED MODALITY THERAPY;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEUROPATHIES;
EVIDENCE-BASED MEDICINE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
PAIN MEASUREMENT;
PRACTICE GUIDELINES;
SOMATOSENSORY DISORDERS;
|
EID: 3042743239
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (5)
|
References (16)
|